Singapore, Nov. 12 -- Canada-based startupAvitia, an artificial intelligence (AI)-powered cancer diagnostics company advancing access to fast and affordable molecular testing, has announced its entry into Thailand through a partnership with The Chitrapatima Foundation, a charitable foundation that was established in 1973.

The Foundation, which develops projects to improve the well-being of the Thai people, will establish Thailand's first advanced liquid biopsy cancer testing ecosystem for hospitals and communities.

Leveraging Avitia's AI-powered precision diagnostics, Thai people can receive more precise treatment guidance through a simple blood test. The initiative supports the Foundation's mandate to advance the nation's health throug...